Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05579392 · ClinicalTrials.gov registry record · NA

A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis

A NA study of Inflammatory Bowel Disease, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
2
Study locations

NCT05579392 is a NA study of Inflammatory Bowel Disease that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 30 participants, below the 403-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05579392, a NA study of Inflammatory Bowel Disease, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the most significant chronic conditions of the gastrointestinal tract (GIT) and affects over 1.5 million individuals in the U.S. Recently, there has been an increased understanding of the importance of sleep and sleep disruption in IBD as a potentially modifiable risk factor. We, therefore, hypothesize that intervening with morning bright light therapy (BLT) in IBD patients with CM will decrease intestinal permeability and pro-inflammatory cytokines, positively impact intestinal microbiota, and improve quality of life (QoL).

Conditions Studied

Inflammatory Bowel Disease

Interventions

  • DEVICE Bright Light Therapy
  • DEVICE Placebo Retimer Device

Study Locations (2)

Illinois

  • Rush University Medical Center - Chicago

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-09-22
Est. Completion 2026-05-31
Phase NA

Sponsor

Rush University Medical Center

320 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05579392

The ClinicalTrials.gov registry entry for NCT05579392 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 403-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (93% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Inflammatory Bowel Disease appearing as the primary indexed condition, and to 2 interventions - of which Bright Light Therapy is the first listed.

NCT05579392 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, South Carolina.

Frequently Asked Questions

What is clinical trial NCT05579392 about?

NCT05579392 is a clinical study titled "A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis". Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the most significant chronic conditions of the gastrointestinal tract (GIT) and affects over 1.5 million individuals in the U.S. Recently, there has been an increased understanding of...

What is the current status of trial NCT05579392?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-09-22. Estimated completion is 2026-05-31.

What conditions does trial NCT05579392 study?

This clinical trial studies the following conditions: Inflammatory Bowel Disease.

What interventions are being tested in trial NCT05579392?

The interventions under investigation include: Bright Light Therapy (DEVICE), Placebo Retimer Device (DEVICE).

Who is sponsoring clinical trial NCT05579392?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05579392 being conducted?

This trial has 2 study locations across Illinois, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Inflammatory Bowel Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Inflammatory Bowel Disease

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.